Gavilán Biodesign

Overcome Drug Resistance

Company Details

Combining low-residual, ML-based computational chemistry and mathematically guaranteed, superlinear search algorithms to find optimized drug candidates when no one else can.

Overcoming Drug Resistance
  • Overcoming Drug Resistance

Company People

Jonathan Jou

Jonathan Jou
Co-Founder

Mark Hallen

Mark Hallen
Co-Founder

Marcel Frenkel

Marcel Frenkel
CEO & Co-Founder

Gavilán Biodesign News

VIEW ALL

You might also be interested in

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision.  Except as expressly stated by SOSV in writing, neither the SOSV website nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities.